Travel grant
| Reference number | |
| Coordinator | iLab Medical AB |
| Funding from Vinnova | SEK 14 800 |
| Project duration | March 2023 - March 2023 |
| Status | Completed |
| Venture | 2023-00007-en |
Important results from the project
Aim: To have at least 6 meetings to establish regional collaborations regarding our new CRC detection and to have meetings with potential financiers, to be able to accelerate the speed of our project Outcome: 12 meetings resulting in several established collaborations and ongoing discussion about funding
Expected long term effects
Expected results Study with Sahlgrenska / Scilife is completed. Agreement regarding the out-licensing of a new CRC panel to Oncobit + Chinese company NN. Validation of a new method for measuring the degree of methylation in CRC. Get funding that wouold enable registration of new panel in US and the expansion of the sales / Marketing organisation Funding covering registration in the USA o new major market/sales organization
Approach and implementation
Book meetings with identified partners for research as well as for funding. Create presentations that are relevant to each group. Positive results / evaluation are written agreements and research collaboration / out-licensing and funding